Literature DB >> 11137287

The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons.

C Finta1, P G Zaphiropoulos.   

Abstract

Using a bacterial artificial chromosome (BAC) clone, we have mapped the human cytochrome P450 3A (CYP3A) locus containing the genes encoding for CYP3A4, CYP3A5 and CYP3A7. The genes lie in a head-to-tail orientation in the order of 3A4, 3A7 and 3A5. In both intergenic regions (3A4-3A7 and 3A7-3A5), we have detected several additional cytochrome P450 3A exons, forming two CYP3A pseudogenes. These pseudogenes have the same orientation as the CYP3A genes. To our surprise, a 3A7 mRNA species has been detected in which the exons 2 and 13 of one of the pseudogenes (the one that is downstream of 3A7) are spliced after the 3A7 terminal exon. This results in an mRNA molecule that consists of the 13 3A7 exons and two additional exons at the 3' end. The additional two exons originating from the pseudogene are in an altered reading frame and consequently have the capability to code a completely different amino acid sequence than the canonical CYP3A exons 2 and 13. These findings may represent a generalized evolutionary process with genes having the potential to capture neighboring sequences and use them as functional exons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137287     DOI: 10.1016/s0378-1119(00)00470-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  27 in total

1.  A statistical view of genome transcription?

Authors:  C Finta; P G Zaphiropoulos
Journal:  J Mol Evol       Date:  2001-08       Impact factor: 2.395

Review 2.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

3.  Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients.

Authors:  C J Kirwan; I A M MacPhee; T Lee; D W Holt; B J Philips
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

Review 4.  Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.

Authors:  Magnus Ingelman-Sundberg; Cristina Rodriguez-Antona
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 5.  The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions.

Authors:  Abdo Haddad; Mellar Davis; Ruth Lagman
Journal:  Support Care Cancer       Date:  2006-12-01       Impact factor: 3.603

Review 6.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

7.  Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations.

Authors:  Takenori Niioka; Hideaki Kagaya; Mitsuru Saito; Takamitsu Inoue; Kazuyuki Numakura; Ryohei Yamamoto; Tomonori Habuchi; Shigeru Satoh; Masatomo Miura
Journal:  Clin Exp Nephrol       Date:  2017-03-07       Impact factor: 2.801

8.  Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment.

Authors:  Kaiser Jamil; Vidya Kandula; Ramoji Kandula; M Asimuddin; Sindu Joshi; Shiva Kumar Yerra
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

9.  Phylogenetic analysis of the cytochrome P450 3 (CYP3) gene family.

Authors:  Andrew G McArthur; Tove Hegelund; Rachel L Cox; John J Stegeman; Mette Liljenberg; Urban Olsson; Per Sundberg; Malin C Celander
Journal:  J Mol Evol       Date:  2003-08       Impact factor: 2.395

10.  Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine.

Authors:  Xiaoping Chen; Haijian Wang; Gangqiao Zhou; Xiumei Zhang; Xiaojia Dong; Lianteng Zhi; Li Jin; Fuchu He
Journal:  Environ Health Perspect       Date:  2009-06-18       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.